Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001593968-21-001217)

Filing Details

Accession Number:: 0001593968-21-001217
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-03 13:00:00
Reporting Period:: 2021-04-01

Accepted Time:: 2021-05-03 17:10:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1771917	Karuna Therapeutics Inc.	KRTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643071	Atul Pande	C/O Karuna Therapeutics, Inc. 99 High Street, 26Th Floor Boston MA 02110		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-01	2,500	$16.00	2,500	No	4	M	Direct
Common Stock	Disposition	2021-04-01	2,500	$120.01	0	No	4	S	Direct
Common Stock	Acquisiton	2021-05-03	2,500	$16.00	2,500	No	4	M	Direct
Common Stock	Disposition	2021-05-03	2,500	$110.61	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2021-04-01	2,500	$0.00	2,500	$16.00
Common Stock	Option (right to buy)	Disposition	2021-05-03	2,500	$0.00	2,500	$16.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000	2020-06-27	2029-06-27	No	4	M	Direct
22,500	2020-06-27	2029-06-27	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.